Apigenin has not been shown to improve sleep in people. The reasons to take it come mostly from mouse and cell experiments. The best-controlled human trial used chamomile extract, which contains apigenin, and it found no significant benefit on its main sleep-diary measures. That does not make apigenin useless. It means the claim is still a hypothesis, and this article lays out what has been tested, what was found and how to think about it.
TL;DR
- No published randomized controlled trial of isolated apigenin for human sleep outcomes turned up in the sources we reviewed.
- A 28-day placebo-controlled trial of chamomile extract in 34 adults with chronic insomnia found no significant difference on primary sleep-diary measures.
- Animal and cell studies suggest a GABA-related mechanism, but mice are not people and these results do not set a human dose.
- Chamomile has some anxiety data, and anxiety and sleep are related but different outcomes.
- If you try apigenin, treat it as an experiment, track your sleep honestly and talk to a clinician if sleep trouble persists.
Table of Contents
- Where the apigenin sleep idea comes from
- What animal and cell studies show
- What human trials have actually tested
- The evidence ladder, in plain terms
- Will your body absorb enough?
- Where the evidence gap leaves you
- A sensible way to approach apigenin
- Other ingredients people compare with apigenin
- Our perspective
- Compare the evidence yourself
- FAQ
- Sources
Where the apigenin sleep idea comes from
Apigenin is a flavonoid found in chamomile, parsley and other plants. It became popular as a sleep aid through podcasts and wellness media, and the headline version goes like this: it acts on the same calming brain pathways as some sleep medications, so it should help you fall asleep.
The first half of that sentence has some laboratory support. The second half has not been demonstrated in a human trial of apigenin itself. A 2024 review in Frontiers in Nutrition describes apigenin's effects on sleep in animal models and also notes that chamomile-extract studies use a mixture. That mixture is often about 0.8% to 1.2% apigenin by mass, so it is hard to say whether an effect comes from apigenin or from other chamomile compounds.
That single point shapes everything below. Most "apigenin helps sleep" claims quietly lean on one of three different kinds of evidence:
- Isolated apigenin in animals or cells.
- Chamomile extract in people.
- Combination products, where apigenin is one of several ingredients.
Only the first is about apigenin alone, and it is not human evidence.
What animal and cell studies show
In a 2012 study, apigenin enhanced pentobarbital-induced sleep behaviors in mice. The same work found it increased chloride influx in cultured cerebellar cells. That fits the GABA-related explanation you will see repeated online: GABA-A receptors let chloride into neurons, which generally calms their activity.
Two cautions keep this finding in proportion.
- The model matters. Enhancing sleep induced by a sedative drug in a mouse is not the same as improving a person's ordinary night of sleep.
- Mechanism is not outcome. A compound can act on a receptor in a dish and still do nothing noticeable once it is swallowed, absorbed, metabolized and distributed in a human body.
Sleep itself is also complicated. Dr. Gotts, quoted in a UK health journal, points out that sleep reflects an interaction of circadian rhythms, sleep pressure, arousal, behavior and environment. A single compound nudging one pathway has a lot of other factors to compete with.
If you want to see how a different sleep ingredient with a plausible mechanism fares in humans, a review of glycine and sleep research shows how modest, specific doses and realistic expectations look on paper. We also cover it in our own glycine for sleep breakdown.
What human trials have actually tested
This is the part most summaries skip. The human data we can point to is about chamomile, not isolated apigenin.
The chamomile insomnia pilot trial
A US randomized, double-blind, placebo-controlled pilot trial enrolled 34 adults with chronic primary insomnia. Participants took 270 mg of chamomile extract twice daily for 28 days. The published results showed no statistically significant differences from placebo on the primary sleep-diary measures:
| Sleep-diary measure | Result vs. placebo |
|---|---|
| Total sleep time | No significant difference |
| Sleep efficiency | No significant difference |
| Sleep latency (time to fall asleep) | No significant difference |
| Wake after sleep onset | No significant difference |
| Sleep quality | No significant difference |
| Number of awakenings | No significant difference |
A pilot trial this small can miss modest effects, so it does not prove chamomile does nothing. It does mean that the best-controlled trial in this area did not deliver the clear win that the marketing implies. An independent summary of apigenin research reaches the same reading: no published randomized controlled trial of isolated apigenin for human sleep outcomes, and no significant improvement in the chamomile trial's main measures.
How the wider chamomile literature reads
The Merck Manual's professional edition describes chamomile clinical evidence as limited and inconsistent. It adds that some randomized evidence suggests possible improvements in sleep quality, though not consistent clinical benefit overall.
That is a fair middle position: there are signals worth following, but nothing solid enough to promise a result. If you want the ingredient-level details, our chamomile profile and our apigenin profile list the studies and how we rate them.
Chamomile and anxiety: a related but separate question
People often fold anxiety evidence into sleep claims, since racing thoughts keep many people awake. There is some anxiety data. An 8-week randomized, placebo-controlled trial in 57 patients with mild-to-moderate generalized anxiety disorder found that chamomile extract produced a significantly greater reduction in Hamilton Anxiety scores (p=0.047).
This is worth knowing, but keep the boundaries clear:
- It tested chamomile extract, not isolated apigenin.
- It measured anxiety symptoms, not sleep.
- It involved people diagnosed with generalized anxiety disorder, so it does not tell us what happens in a healthy sleeper.
If anxiety is what keeps you up, our write-ups on L-theanine and anxiety and magnesium and anxiety cover ingredients with their own evidence trails.
The evidence ladder, in plain terms
It helps to rank the kinds of evidence you will run into, from weakest to strongest, and see where apigenin sits.
| Evidence type | What it can tell you | Apigenin and sleep status |
|---|---|---|
| Cell experiments | A mechanism is possible | Chloride influx in cultured cerebellar cells reported |
| Animal studies | An effect can occur in a living body | Enhanced pentobarbital-induced sleep in mice |
| Small human trials of a related extract | A signal worth testing further | Chamomile pilot: no significant primary effects |
| Randomized trials of the isolated compound | Whether the compound itself works | None identified |
| Repeated large trials | How reliable the effect is | None |
The honest label for apigenin and sleep is "plausible, unproven in humans." That is the rating we would give it, and it is a different thing from "does not work."
Will your body absorb enough?
Even when a mechanism looks good, absorption decides whether it matters. The data here is mostly from animals and food studies, so read it as background.
Rat pharmacokinetic studies reported peak circulating levels 0.5 to 2.5 hours after oral apigenin, with an average elimination half-life of 2.52 ± 0.56 hours. The same review estimates oral bioavailability at roughly 30% and suggests capsule supplements could reach target blood levels, while noting that modified formulations may be suitable but may not be necessary.
Food is a different story. In a study of apiin-rich parsley, 24-hour urine contained only 0.22% (±0.16%) of the ingested apigenin dose. That suggests that tea or herbs deliver very little compared with a concentrated product, which is one reason people look to supplements. It also means chamomile tea trial results cannot be mapped neatly onto apigenin capsules.

None of this establishes a human sleep dose for apigenin. If a label or influencer quotes a precise number as "the sleep dose," ask what human trial it came from. As far as we could find, there is not one.
Where the evidence gap leaves you
When the evidence is thin, people sometimes jump to whatever device or compound has a cleaner trial story. One example is PEMF for sleep, which is built around a four-week trial. Whatever you consider, the question to ask is the same one we apply to apigenin: what was tested, in whom, for how long, and against what control?
A sensible way to approach apigenin
If you decide to try it anyway, here is a low-risk framework built on what the evidence supports.
- Fix the basics first. Consistent bed and wake times, a dark and cool room and limited late caffeine and alcohol have a better evidence base for sleep than any single supplement.
- Pick one change at a time. If you start apigenin, magnesium and a new bedtime routine in the same week, you will not know what did what.
- Track outcomes. Write down how long it takes to fall asleep, how many times you wake and how rested you feel, for two weeks before and four weeks after. The chamomile trial ran 28 days, which is a reasonable benchmark.
- Be realistic. If nothing changes after a month, that is useful information. Stop and move on.
- Check with a professional if you take medication. If you use prescription sedatives, anxiety medication or other drugs, or you are pregnant or have a medical condition, ask your doctor or pharmacist before adding any herbal compound.
Persistent trouble sleeping, loud snoring with daytime sleepiness, or insomnia lasting weeks deserves a conversation with your doctor, since sleep apnea and other conditions need diagnosis rather than supplements.
Other ingredients people compare with apigenin
If your real goal is better sleep, you may want to see how apigenin sits next to alternatives in the same category. Our guides cover glycine, ashwagandha and sleep and which magnesium form suits sleep and anxiety. Each is rated on the same scale, so you can compare how much human evidence stands behind it. For the longer version of this topic, see our apigenin and sleep deep dive, and our Apigenius® profile if you are looking at that specific branded form.
Our perspective
We built NutraSmarts because supplement claims usually arrive faster than the research behind them. Apigenin is a good example. The story is compelling: a plant compound, a calming mechanism, a bedtime ritual. But when we trace it back to the citations, the human sleep data for isolated apigenin is not there yet.
That is why we rate evidence instead of selling excitement. Our database links ingredient profiles to peer-reviewed studies and clinical trial citations, and we show clinical dosage benchmarks so you can see what was actually tested. For apigenin, that means telling you plainly that the chamomile trial missed its primary measures and that mouse data is not a dose recommendation.
We think this makes you a better decision-maker, not a more skeptical one for its own sake. When you can see that an ingredient has animal data, a small human signal or a full set of randomized trials, you can match your expectations and your budget to it. Our side-by-side comparison tool exists for exactly that purpose.
NutraSmarts
Compare the evidence yourself
We keep the research for 1,300+ ingredients in one place, with no sign-up and no paywall. Start with supplements organized by symptom if you know the problem (such as poor sleep or anxiety) but not the ingredient, or use the side-by-side comparison guides to put apigenin next to other options.

If you formulate products, our free Supplement Facts label creator runs in your browser and builds FDA-compliant labels without spreadsheets. You can also browse the full library from the NutraSmarts home page.
FAQ
Does apigenin help you sleep?
There is no published randomized controlled trial showing that isolated apigenin improves human sleep. Animal studies suggest it can enhance sedative-induced sleep in mice, and chamomile, which contains apigenin, has mixed human results. Right now it is a plausible idea rather than a proven one.
Is chamomile tea a good source of apigenin for sleep?
Chamomile is a natural source, but the amounts are small and the trial evidence is mixed. A parsley study found that only a tiny fraction of ingested apigenin showed up in urine, which points to limited absorption from food. A warm cup of tea may still be a pleasant bedtime ritual, which can help some people wind down.
What dose of apigenin is used for sleep?
No human sleep dose for isolated apigenin has been established by randomized trials. The chamomile pilot used 270 mg of chamomile extract twice daily for 28 days, and that is extract, not pure apigenin. Be wary of any label that presents a specific apigenin number as proven.
Is apigenin different from the chamomile extract used in trials?
Yes. Chamomile extract is a mixture, often about 0.8% to 1.2% apigenin by mass, so effects could come from other compounds. That is why chamomile trial results cannot simply be credited to apigenin.
Who should talk to a doctor before trying apigenin?
Anyone taking prescription sedatives or anxiety medication, anyone who is pregnant or nursing and anyone with a medical condition should ask a doctor or pharmacist first. The same goes for anyone whose sleep problems have lasted several weeks, since the cause may need a diagnosis.
Sources
- Frontiers in Nutrition: Apigenin, a natural molecule at the intersection of sleep and aging
- Enhancement of pentobarbital-induced sleep by apigenin (Archives of Pharmacal Research, 2012)
- Healf: What Is Apigenin, And Can It Really Improve Sleep?
- Preliminary examination of the efficacy and safety of a standardized chamomile extract in chronic primary insomnia (BMC Complementary and Alternative Medicine, 2011)
- Apigenin for Sleep: Does This Chamomile Compound Work?
- Merck Manual Professional Edition: Chamomile
- Randomized, double-blind, placebo-controlled trial of chamomile extract for generalized anxiety disorder (PMC)
- Does Oral Apigenin Have Real Potential for a Therapeutic Effect? (PMC, 2021)
- Bioavailability of apigenin from apiin-rich parsley in humans (PubMed, 2006)
- Glycine for Sleep: What 3 Grams Can (and Can't) Do
- PEMF for Sleep: Can Your Device Match the 4-Week Trial?
